Aug 08, 2016 - Allergan Plc (NYSE:AGN)Q2 2016 Earnings CallAugust 08, 2016 8:30 am ETExecutivesLisa M. DeFrancesco - Vice President-Investor RelationsBrenton L. Saunders - President, Chief Executive Officer & Direct
Aug 05, 2016 - As the Q2 earnings cycle draws to a close, the overall picture that has emerged does not appear as grim as we feared.
Aug 05, 2016 - In addition to reporting better-than-expected results, Teva (TEVA) also closed the Actavis Generics deal and announced it will be acquiring Allergan's Anda business.
Aug 04, 2016 - Allergan's (AGN) Earnings ESP, which represents the difference between the Most Accurate estimate and the Zacks Consensus Estimate, is a negative 1.49% - will the stock disappoint?
Aug 02, 2016 - Biogen (BIIB) stock jumped 8% on late-afternoon trading on Tuesday on rumors that the company could be bought out by either Allergan (AGN) or Merck (MRK), both large-cap pharmaceutical companies.
Aug 02, 2016 - Our proven model shows that Teva (TEVA) is likely to beat earnings this quarter because it has the right combination of two key ingredients.
Jul 19, 2016 - Boston Scientific Corporation (BSX) is scheduled to report its second-quarter 2016 results before the opening bell on Jul 28.
Jul 19, 2016 - Hologic (HOLX) has a Zacks Rank #2 (Buy) which along with a 0.00 % ESP makes surprise prediction difficult.
Jul 19, 2016 - Illumina (ILMN) has a Zacks Rank #4 (Sell), which along with an ESP of 0.00% makes surprise prediction difficult.
Jul 18, 2016 - Edwards (EW) has a Zacks Rank #4 (Sell), which along with a negative ESP of -1.43% makes surprise prediction difficult.